Ambu stock gains ahead of the open after USD 65 million deal
Published on 09/23/2026 at 05:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Ambu stock closed at a documented Nasdaq Copenhagen price on September 22, 2026, after the shares gained in connection with a medical technology acquisition valued at up to USD 65 million. The available session report identifies the primary venue and the dated transaction, but does not provide a complete closing quote, daily percentage change, range or volume.
September 22, 2026 and the acquisition
Ambu A/S (ISIN DK0060946788, Nasdaq Copenhagen: AMBU B) was associated with the acquisition of U.S.-based TIMS Medical, which trades as Foresight Imaging. As Ad Hoc News reported on September 22, 2026, the consideration comprised USD 45 million upfront and up to USD 20 million in milestone payments.
The same report said Ambu kept its fiscal year 2025/26 guidance unchanged after the September 21, 2026 transaction. The acquisition was presented as intended to accelerate revenue growth and advance imaging capability, while the milestone structure leaves USD 20 million of the maximum consideration conditional.
Today and the next company update
The acquisition terms and unchanged guidance remain the dated company-specific items framing Ambu stock ahead of the September 23, 2026 session. The next reporting date is not stated in the substantiating material available for this article.
